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Percutaneous Transhepatic Biliary Drainage (PTBD) is performed in surgical jaundice to
decompress the biliary tree and improve hepatic functions. However, the risk of sepsis is high
in these patients due to immunosuppression and surgical outcome remains poor. This raises a
question--can we do away with PTBD? To answer this query a study was carried out in 4
groups of patients bearing in mind the high incidence of sepsis and our earlier studies, which
have demonstrated immunotherapeutic potential of Tinospora cordifolia (TC): (A) those
undergoing surgery without PTBD (n 14), (B) those undergoing surgery after PTBD
(n 13). The mortality was 57.14% in Group A as compared to 61.54% in Group B. Serial
estimations of bilirubin levels carried out during the course of drainage (3 Wks) revealed a
gradual and significant decrease from 12.52 + 8.3 mg% to 5.85 + 3.0 mg%. Antipyrine half-life
did not change significantly (18.35 + 4.2 hrs compared to basal values 21.96 + 3.78 hrs). The
phagocytic and intracellular killing (ICK) capacities of PMN remained suppressed (Basal:
22.13 + 3.68% phago, and 19.1 + 4.49% ICK; Post drainage: 20 + 8.48% Phago and 11.15 +
3.05% ICK). ThusPTBD did not improve the metabolic capacity ofthe liver and mortality was
higher due to sepsis. Group (C) patientg received TC during PTBD (n 16) and Group (D)
patients received TC without PTBD (n 14). A significant improvement in PMN functions
occurred by 3 weeks in both groups (30.29 + 4.68% phago, 30 + 4.84% ICK in Group C and
30.4 + 2.99% phago, 27.15 + 6.19% ICK in Group D). The mortality in Groups C and D was
25% and 14.2% respectively during the preoperative period. There was no mortality after
surgery. It appears from this study that host defenses as reflected by PMN functions play an
important role in influencing prognosis. Further decompression of the biliary tree by PTBD
seems unwarranted.
KEYWORDS: PTBD immunosuppression sepsis PMN cells Tinospora
cordifolia, host defences.
INTRODUCTION
The increased risk of surgery in patients with surgical
jaundice is well known 1,2,3. Since the introduction of
percutaneous drainage techniques in 19744, the initial
reports on preoperative external biliary drainage were
of dramatic reduction in post-operative mortality-2.
Recent trials have however emphasized the compli-
cations of drainage techniques thus questioning the
advantages of this method13,14,15. The hazards of the
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technique include cholangitis, haemorrhage, biliary
leakage, catheter blockage/dislodgement.
The incidence of sepsis following external biliary
drainage has been reported to be between 22-
33/017’18’19. Impairment of function of the immune sys-
tem in patients with obstructive jaundice has been
suggested as the underlying cause for sepsis19-)9. To
control infection, antibiotics have been used, compli-
cating the therapy with development of resistant
organisms. Strengthening of host defences is a novel
approach which may be complementary to antibiotics
to combat infection in patients with obstructive
jaundice.
Recently, Tinospora cordifolia, a plant from the
traditional Indian system ofMedicine (Ayurveda), has6 R.D. BAPAT et al.
been shown to improve the surgical outcome in
patients with obstructive jaundice by strengthening
the host defences3. Tinospora cordifolia was adminis-
tered to patients after institution of external biliary
drainage and was continued during the entire drainage
period. It is available in the form ofpills which contain
dried aqueous extract of the stem of the plant. Earlier
reports31,32 have shown its protective, effect against a
variety of infections and this has been attributed to its
immunostimulant property.
The beneficial effect of Tinospora cordifolia in
patients undergoing percutaneous drainage prompted
us to conduct the present study. In the present study
we aimed at evaluating the effects ofTinospora cordi-
folia in patients with obstructive jaundice undergoing
biliary tract surgery, without preoperative Per-
cutaneous Transhepatic Biliary Drainage (PTBD) and
compared the results with those undergoing pre
operative PTBD and recieving Tinospora cordifolia.
The changes in bilirubin, antipyrine half-life and poly-
morphonuclear functions in terms of phagocytosis
and intracellular killing capacity ofneutrophils, along
with perioperative mortality and morbidity were
observed and noted. The efficacy of Tinospora cordi-
folia was also viewed in the light of changes observed
in these parameters in patients who underwent surgery
alone or following biliary drainage but did not receive
Tinospora cordifolia.
MATERIALS AND METHODS
A prospective study was carried out with the approval
of the Hospital Ethics committee, in 57 consecutive
patients with suspected malignant extrahepatic biliary
tract obstruction. The diagnosis was confirmed by
ultrasonography, percutaneous transhepatic cholan-
giography and/or ERCP. The final proofofmalignant
disease was obtained by peroperative biopsy (or
autopsy in patients who died preoperatively). The
patients with disseminated malignancy, hepatocellular
carcinoma, patients presenting with complications,
those with other associated diseases, pregnant women
and those taking other traditional drugs/remedies
were excluded from the study. Malignant lesions
included carcinoma of head of pancreas (n 27),
ampullary carcinoma (n 16), carcinoma gall bladder
(n 10), cholangiocarcinoma (n 2) and metastases
at porta hepatis (n 2).
There were 37 men and 20 women who were
included in the study. The age range was 17 to 73 yrs;
median age being 48.5 yrs. The median weight for the
group was 42.5 kg. The median duration ofillness was
45 days. Written, informed consent was obtained from
each patient before randomly allocating them into 4
groups.
Group A: Patients directly underwent surgery with-
out preoperative PTBD (n 14).
Group B: Patients underwent PTBD preoperatively
for 3 weeks, followed by surgery (n 13).
Group C: Patients underwent PTBD and received
treatment with Tinospora cordifolia pre-
operatively for 3 weeks, followed by
surgery (n 16).
Group D: Patients received treatment with Tinos-
pora cordifolia only, pre-operatively for 3
weeks, followed by surgery (n 14).
Tinospora cordifolia was used in the form of pills
prepared from dried aqueous extract ofthe stem ofthe
plant; (1 pill 65 mg). The dose selected was 16 mg/
kg/day in 3 divided dose and was extrapolated from
previous animal experiments26.
All patients received Vitamin K and perioperative
antibiotics. Biliary enteric bypass surgery was done in
all cases.
At the time of admission a profile of liver function
tests, renal chemistry and haemogram was obtained.
Metabolic function of the liver was assessed by
determining the half-life ofelimination ofantipyrine34.
10 ml of venous blood was collected in a sterile hep-
arinized tube for determination of phagocytic and
killing capacities of neutrophils3. These values
assessed on admitting the patients were considered as
basal values. In the groups undergoingPTBD (Group
B and C), in addition to above tests, bile was collected
for culture and antibiotic sensitivity at the time of
insertion of drain, weekly during the period of drain-
age and intra-operatively. Weekly assessment was
carried out by determining- plasma bilirubin (total
and direct), antipyrine half-life (t 1/2) 34,37 and phago-
cytic and killing activity ofneutrophils3. Pre and post-
operative mortality and morbidity were noted.
RESULTS
All the four groups were matched with respect to
clinical features, demographic data and parameters
assessed at the time of admission (basal values).
Group A: The basal plasma bilirubin levels were 2.9 +
6.4 mg% total bilirubin and 7.2 + 10.1 mg% directCANWE DOAWAY WITH PTBD? 7
Table 1 Changes in total and direct bilirubin, antipyrine half-life over a period of 3 weeks in patients with obstructive jaundice.
Total Bilirubin Direct Bilirubin Antipyrine tl/2
(mg/o) (mg%) (hrs)
Weeks 0 2 3 0 2 3 0 2
NS NS NS
GroupA 12.9 13.63 14.12 14.19 7.2 8.0 8.34 8.61 21.23 22.36 24.7 25.8
(n 14) +6.4 +6.1 +5.2 +5.4 +10.1 +5.3 +2.3 +1.41 +5.6 +6.3 +5.4 +6.4
NS
Group B 12.52 8.1 6.9 5.85* 7 5.29 4.48 3.6* 21.96 20.65 19.14 18.35
(n 13) +8.37 +5.3 +3.4 +3.0 +4.2 +3.9 +3.0 +2.1 +3.78 +2.1 +3.7 +4.2
NS
Group C 9.4 7.2 5.2 4.43* 6.96 5.34 3.38* 3.5* 19.49 22.2 21.88 17.13
(n 16) +2.68 +1.6 +2.3 +2.1 +2.19 +1 +1.68 +2.4 +3.14 +2.85 +8.74 +0.18
NS NS NS
GroupD 10.06 9.43 8.2 8.48 7.4 6.4 5.32 5.9 23.23 21.65 20.18 19.38
(n 14) +3.4 +4.3 +2.4 +2.82 +2.87 +3.67 +2.17 +2.02 +3.9 +2.8 +3.43 +4.46
Paired ’t’ test; p < 0.05; NS not significant.
bilirubin. The basal antipyrine half-life was 21.23 +
5.6 hours, which was found to be significantly pro-
longed as compared to normal values (APt1/2
14-16 hrs). The polymorphonuclear functions in
terms of % phagocytosis and % intracellular killing
capacity ofneutrophils were 21.23 + 5.1% and 17.87 +
4.5% respectively. These values were significantly
lower then those established for 30 normal healthy
individuals (30.4 + 5.1% phago, P < 0.01 and 26.41 +
4.4% ICK; p<0.05). Bilirubin estimation and
antipyrine t 1/2 determined preopera-tively were as
follows: total bilirubin 14.19 + 5.4mg% direct
bilirubin 8.61 + 1.41 mg% and Ap tl/2 25.8 + 6.4 hrs.
The perioperative mortality in this group was 57.14%
(8/1.4). Of these 5 patients died of liver cell failure, 2
of septicaemia and of biliary peritonitis which
developed secondary to anastomotic leak.
Group B: In patients who underwent preoperative
PTBD there was a significant decrease in the bilirubin
levels at the end of 3 weeks of drainage. The total and
direct plasma bilirubin levels decreased to 5.85 +
3 mg% and 3.6 + 2.1 mg% respectively from initial
values of 12.52 + 8.3 mg% and 7 + 4.2 mg% (P < 0.05).
However the antipyrine half-life did not show any
significant change inspite of 3 weeks of drainage (Pre-
drainage value: 21.96 + 3.78 hrs and 3 weeks post-
drainage value: 18.35 + 4.2 hrs). The basal phagocytic
and killing capacities of neutrophils in these patients
were found to be depressed as compared to normal
values (22.13 + 3.68% phago and 19.1 + 4.49% ICK;
P < 0.05). A further suppression ofthese functions was
observed during the drainage period; 20 + 8.48%
phago and 11.15 + 3.05% ICK (P < 0.05).
Complications seen during the drainage period
were substantial. These were, catheter blockage in 2
patients, cholangitis in 2 patients, bile leak in peri-
toneal cavity due to kinking of catheter between
abdominal wall and liver in patient, mild renal
failure which was reversible in patient, pneumonia in
2 patients and pleural effusion in patient. The peri-
operative mortality was 61.54% (8/13). 3 patients died
of liver cell failure, 4 patients of septicaemia and
patient of acute renal failure.
Group C: As was seen in Group B, patients from this
group who also underwent preoperative PTBD
showed a significant decrease in bilirubin levels. At the
end of 3 weeks of drainage total bilirubin decreased
from 9.4 + 2.68 mg% to 4.43 + 2.1 mg% and direct
bilirubin from 6.96 + 2.19 mg% to 3.5 + 2.4 mg%.
However,. antipyrine half-life did not show a signi-
ficant change (basal value: 19.49 + 3.14 hrs and 3
weeks post drainage value: 17.13 + 0.18 hrs). The
basal values of % phagocytosis and % intracellular
killing capacity ofneutrophils were significantly lower
than normal values (19.4 + 7.07% phago and 18.61 +
8.79% ICK). However at the end of 3 weeks, a
significant rise in both the functions was observed
(30.29 + 4.68% phago and 30 + 4.84% ICK). These
values were comparable to normal values of these
functions.
Three patients developed wound infection, had
GI haemorrhage and patient developed pneumonia.
The perioperative mortality was 25% (4/16). One patient
died of bile peritonitis following catheter breakage.
Repositioning was with great difficulty. Post-mor-
tem revealed multiple intra-abdominal abscesses.8 R.D. BAPAT et al.
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Figure 1 Effect ofPTCD onPMN function (Group B)PMN functions.
Two patients died ofsepticaemia ofwhich had severe
GI haemorrhage and bleeding from the drain. One
patient died of liver cell failure.
Group D: The patients who received only Tinospora
cordifolia therapy during preoperative period, showed
a decrease in bilirubin levels at the end of 3 weeks of
treatment (Total bilirubin: from 10.06 _+ 3.4 mg% to
8.48 _+ 2.82 mg% and direct bilirubin: from 7.4 _+
2.87 mg% to 5.9 _+ 2.02 mg%) but the difference was
not significant. Antipyrine levels did not show any
significant change (Basal: 23.23 _+ 3.9 hrs and post
Tinospora cordifolia therapy: 19.38 _+ 4.46 hrs).
The basal % phagocytosis and % intracellular
killing capacity were significantly depressed (22.72 _+
6.25% Phago and 18.36 _+ 4.25% ICK) as compared to
normal values. At the end of3 weeks oftreatment with
Tinospora cordifolia both functions showed a dra-
matic rise to near normal levels (30.4 _+ 299% Phago
and 27.51 _+ 6.19% ICK).
One patient developed wound infection and
patient had pneumonia which were treated effectively.
The perioperative mortality was 14.2% (2/14). One
patient died of septicaemia and the other of liver cell
failure.
DISCUSSION
Biliary decompression and curative/palliative surgery
are performed in obstructive jaundice. However these
procedures are associated with considerable morbidity
and mortality. The main complications are sepsis,
renal failure, haemorrhage and impaired wound
healing35,36. These have been associated with deranged
36 hepatic function, portal and systemic endotoxaemia
The deranged hepatic function was considered the
underlying mechanism responsible for various com-
plications in jaundiced patients. Preoperative biliary
drainage therefore provided a logical solution to
prevent postoperative complications. Biliary decom-
pression was thought to allow the hepatocytes to
regain their functional capacity. This approach was
followed enthusiastically and the initial reports
showed a reduction in postoperative mortality from
28% to 80//06. Recent prospective studies 13,14,15 however
do not confirm the benefits of preoperative biliary
drainage. The hazards of this technique outweigh the
possible advantages. Thus there appear to be two
schools of thought 1. to carry out surgery taking the
risk ofpostoperative complications 2. to operate after
PTBD.CANWEDOAWAYWITH PTBD? 9
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Figure 2 Effect ofTC on PMN function (Group C & D) PMN functions.
In the present study in group A where patients
underwent surgery without preoperative drainage the
mortality was 57.14%. The high levels ofBilirubin and
prolonged half-life of antipyrine indicated deranged
hepatic function. Deaths due to septicemia indicate
poor host defences. Indeed all patients showed
suppression of polymorphonuclear function in terms
of phagocytic and intracellular killing capacities of
neutrophils (Fig. 1).
In group B where patients underwent preoperative
drainage there was a significant fall in bilirubin levels
over a period of3 weeks ofdrainage. Often the plasma
bilirubin level is taken as a guideline for improvement
in hepatic function and the patient is taken up for
surgery when bilirubin levels decrease. However as
seen in our study, the reduction in bilirubin level is not
accompanied by improvement in half-life of anti-
pyrine. Even though the bilirubin levels were halved,
antipyrine half-life, an indicator ofmetabolic function
of liver remained prolonged (Table 1). This indicates
that esti-mation ofbilirubin levels alone will not give a
true measure of the functional capacity of the liver.
Such a patient if operated would still carry a high risk
ofpostoperative complications. This fact has also been
stressed by McPherson et al. 37. The most dreaded
complication after PTBD is sepsis. In this group (B)
bile was sterile at the time of insertion of drain but the
culture po,sitivity increased with increasing duration of
drainage, and 11 of 13 patients showed bactobilia
during the drainage period despite strict aseptic
precautions and antibiotics. 4 out of 13 patients died
in septicemia. In all these patients the basal PMN
functions were depressed. It is noteworthy that after
PTBD there is further suppression of phagocytosis
and intracellular killing capacity ofneutrophils, which
is possible due to secondary sepsis (Fig. 1). Sepsis is
also the limiting factor which prevents optimal
drainage till the liver functions return to normal which
may well exceed 3 weeks. In spite ofdecompressing the
biliary system by PTBD liver functions did not
improve and the majority of patients (7/8) died from
septicemia (4/7) and liver cell failure (3/7). The10 R.D. BAPAT et al.
drainage associated complications were multiple and
significant.
Addition of an immunostimulant to the therapeutic
armamentarium (Group C) was found to improvePMN
functions (Fig. 2). Even though the duration ofPTBD
remained the same as in Group B, there was a fall in post
operative mortality (25% in Group C VS 61.54% in
Group B). The mortality following septicaemia was
lowered (12.5% in GroupCVS 30.76% in Group B). The
antipyrine half-life remained virtually unaltered. The
relation between improvement of host defences and
survival cannot be explained from this study. In our
earlier study
26 in patients with obstructive jaundice due
to malignant lesions, an improved survival in the group
which received Tinospora corditolia (92% sur-vival VS
40% survival in patients not receiving the drug) was
associated with bolstering ofdepressedPMN functions.
Similarly the reduction both in post-operative mortality
and that following septicaemia may be attributed to the
enhancedPMN function.
The question which was to be answered was
whether we can do away with preoperative external
biliary drainage and treat the patients only with an
immunostimulant during the preoperative manage-
ment of the jaundiced patient. In Group D patients
were treated for 3 weeks with Tinospora cordifolia
following which they underwent surgery without
preoperative PTBD. During this period there was no
significant rise in the bilirubin levels and half-life of
antipyrine (Table 1). This cannot be explained conclu-
sively, however a hepatoprotective effect ofTinospora
cordi-folia has been evaluated in various models of
liver diseases32,33. The PMN functions after 3 weeks
of Tinospora cordifolia therapy have risen to near
normal levels (Fig. 2). This group showed the least
overall mortality (14.2%) and also the lowest
mortality from septicaemia (7.15%).
There appears to be no advantage associated with
external biliary drainage before surgery in obstructive
jaundice. It is associated withmany complications and
there is no improvement in metabolic function of the
liver. On the contrary there is further suppression of
host defences which will compound the problems
faced in obstructivejaundice.
Non specific host defences appear to be the most
important prognostic factor. Immunomodulators
such as Tinospora cordifolia reduce the risk involved
and improve the outcome after surgery in obstructive
jaundice and should be included in the preoperative
management of the jaundiced patients. Immuno-
modulation is the need of the hour and PTBD should
be avoided to prevent sepsis and immunosuppression.
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